Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

Journal of Pediatrics

Volumn 144, Issue 1, 2004, Pages 23-29

  Ibáñez, Lourdes ^a   Ferrer, Angela ^b   Ong, Ken ^b   Amin, Rakesh ^b   Dunger, David ^b   De Zegher, Francis ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DIANBEN; GONADORELIN AGONIST; GONADOTROPIN; GROWTH HORMONE; INSULIN; LEUPRORELIN; LIPID; METFORMIN; SOMATOMEDIN C;

ADOLESCENCE; AGE; ANDROGEN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; GROWTH HORMONE RELEASE; HIGH RISK POPULATION; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; LOW BIRTH WEIGHT; MENARCHE; ONTOGENY; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RANDOMIZATION; SENSITIZATION;

EID: 0346171340     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2003.08.015     Document Type: Article

References (38)

1. Ibáñez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76:1599-603.
2. Ibáñez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-62.
3. Ibáñez L, Potau N, de Zegher F. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth. Pediatr Res 1999;46:320-2.
4. Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 2001;16:1255-60.
5. Ibáñez L, Ong K, de Zegher F, Marcos MV, del Rio L, Dunger DB. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinemia and androgenemia from prepuberty to postmenarche. Clin Endocrinol 2003;58:372-9.
6. Ibáñez L, Potau N, Marcos MV, de Zegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestationaJ age. J Clin Endocrinol Metab 1999;84:4739-41.
7. Ibáñez L, Valls C, Potau N, Marcos MV, de Zegher F. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab 2000;85:3526-30.
8. Ibáñez L, Valls C, Ferrer A, Marcos MV, Rodriguez-Hierro F, de Zegher F. Sensitization to insulin induces ovulation in non-obese adolescents with anovulatory hyperandrogenism. J Clin Endocrinol Metab 2001;86: 3595-8.
9. Ibáñez L, Potau N, Ferrer A, Rodriguez-Hierro F, Marcos MV, de Zegher F. Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism. J Clin Endocrinol Metab 2002;87:5702-5.
10. Ibáñez L, Valls C, Potau N, Marcos MV, de Zegher F. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Clin Endocrinol 2001;55:667-72.
11. Hanley AJG, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TMS, Kwan J, et al. Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentration. J Clin Endocrinol Metab 2002;87:77-83.
12. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men. Arterioscler Thromb Vase Biol 1997;17:107-13.
13. Garcia-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome. Eur J Endocrinol 2002;147: 207-16.
14. Rosenfield RL. Normal and almost normal precocious variations in pubertal development: premature pubarche and premature thelarche revisited. Horm Res 1994;41(Suppl 2):7-13.
15. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
16. Vidal-Puig A, Moller DE. Insulin resistance: classification, prevalence, clinical manifestations, and diagnosis. In: Azziz R, Nestler JE, Dewailly D, editors. Androgen Excess Disorders in Women. Philadelphia: Lippincott-Raven Publishers; 1997. p. 227-36.
17. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2283-8.
18. Ibáñez L, Valls C, Miró E, Marcos MV, de Zegher F. Early menarche and subclinical ovarian hyperandrogenism in girls with reduced adult height after low birthweight. J Pediatr Endocrinol Metab 2002;15:431-3.
19. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
20. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983;56:320-5.
21. 5-steroid levels. J Clin Endocrinol Metab 1996;81:3961-5.
22. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7.
23. Dunger DB, Matthews DR, Edge JA, Jones J, Preece MA. Evidence for temporal coupling of growth hormone, prolactin, LH and FSH pulsatility overnight during normal puberty. J Endocrinol 1991;130:141-9.
24. Ibáñez L, Potau N, Ong K, Dunger DB, de Zegher F. Increased bone mineral density and serum leptin in non-obese girls with precocious pubarche: relation to low birthweight and hyperinsulinism. Horm Res 2000;54:192-7.
25. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998;67:44-9.
26. Kiebzak GM, Leamy LJ, Pierson LM, Nord RH, Zhang ZY. Measurement precision of body composition variables using the Lunar DPX-L densitometer. J Clin Densitometry 2000;3:35-41.
27. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 1990;71:1356-62.
28. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2.
29. Freemark M. Clinical perspective: pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients. J Clin Endocrinol Metab 2003;88:3-13.
30. Hediger ML, Overpeck MD, Kuczmarski RJ, McGlynn A, Maurer KR, Davis WW. Muscularity and fatness of infants and young children born small -or large-for-gestational age. Pediatrics 1998;102:e60.
31. Mericq V, Bazaes R, Peña V, Salazar T, Iñiguez G, Avila A, et al. The impact of being born small for gestational age on size and insulin sensitivity at birth and 1 year. Proceedings of the 84th Annual Meeting of The Endocrine Society, San Francisco, California, 2002; OR62-6 (Abstract).
32. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997;82:402-6.
33. Bavdekar A, Chittaranjan SY, Fall CHD, Bapat S, Pandit AN, Deshpande V, et al. Insulin resistance syndrome in 8-year-old Indian children. Diabetes 1999;48:2422-9.
34. Garnett SP, Cowell CT, Baur LA, Fay RA, Lee J, Coakley J, et al. Abdominal fat and birth size in healthy prepubertal children. Int J Obes Relat Metab Dis 2001;25:1667-73.
35. Ibáñez L, Ferrer A, Marcos MV, Rodriguez-Hierro F, de Zegher F. Early puberty: rapid progression and reduced final height in girls with low birthweight. Pediatrics 2000;106:e72.
36. Chiarelli F, di Ricco L, Mohn A, De Martino M, Verrotti A. Insulin resistance in short children with intrauterine growth retardation. Acta Paediatr 1999;88(Suppl 428):62-5.
37. Ibáñez L, Valls C, Ferrer A, Ong K, Dunger D, de Zegher F. Additive effects of insulin-sensitizing and antiandrogen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia and anovulation. J Clin Endocrinol Metab 2002;87:2870-4.
38. Ibáñez L, Ong K, Ferrer A, Amin R, Dunger D, de Zegher F. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. J Clin Endocrinol Metab 2003;88:2600-6.